Current and future strategies for vaccinating against invasive pneumococcal disease

FHS
August 23, 2023
10:07 am

Researchers reviewed the immune mechanisms employed by existing vaccines for invasive pneumococcal disease.

Why Biogen is purposefully becoming more risk averse, according to Biogen’s CEO

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Lots for you today

October 20, 2023

GSK’s mRNA flu shot is heading to Phase 3; Summit’s $235M offering

Plus, news about Oruka Therapeutics, Centessa, Takeda, Innate Pharma and Liquidia: GSK’s mRNA flu vaccine succeeds against both strains in Phase 2: The pharma company

September 13, 2024

Keeler: CU Buffs’ Deion Sanders, CSU Rams’ Jay Norvell both need Rocky Mountain Showdown win. After Nebraska, though? Coach Prime needs it more – The Cannabist

BOULDER — When the bully across the road gives you a wedgie on national TV, the neighbors start to worry. Get beat by little brother?

September 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.